ClinicalTrials.Veeva

Menu

Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy (MINDBP)

Medical College of Wisconsin logo

Medical College of Wisconsin

Status

Begins enrollment this month

Conditions

Preeclampsia

Treatments

Behavioral: Garmin Vivoactive 4 watch
Behavioral: Mindfulness training

Study type

Interventional

Funder types

Other

Identifiers

NCT07218237
PRO00056473

Details and patient eligibility

About

The MINDBP study will enroll 90 pregnant women at risk for HDP across two sites (MCW and Brown) and randomize them to: (1) mindfulness training (MT) plus wearable biosensors, (2) MT alone, or (3) routine prenatal care. MT participants will receive 8 weekly phone-based MT sessions plus two booster sessions at 1 and 2 months post-intervention. The primary outcome is study feasibility.

Full description

The MINDBP study will enroll 90 pregnant women at risk for HDP across two sites (MCW and Brown) and randomize them to: (1) MT + wearable biosensors, (2) MT alone, or (3) routine prenatal care. MT participants will receive 8 weekly phone-based MT sessions plus two booster sessions at 1 and 2 months post-intervention. All participants will wear Garmin Vivoactive 4 watches. Blood pressure, heart rate, heart rate variability, perceived stress, and pregnancy-related anxiety will be assessed at baseline (≤16 weeks), post-intervention (~24 weeks), and after each booster (~28 and 32 weeks). Feasibility, fidelity, and acceptability outcomes will be assessed after each post-intervention

Enrollment

90 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant patients at gestational age <= 16 weeks
  • Live, non-anomalous gestation
  • Normotensive at enrollment
  • Meet criteria consistent with 'moderate' to 'high' risk for preeclampsia based on ACOG/USPSTF guidelines for low-dose aspirin administration to prevent hypertensive disorders of pregnancy

Exclusion criteria

  • Multiple gestation
  • Chronic (pregestational hypertension)
  • Inability of unwillingness to provide informed consent
  • Active suicidality or psychosis
  • Ongoing mind-body practice (e.g., yoga, meditation, mindfulness >= once per week)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

90 participants in 3 patient groups

MT + Biofeedback
Experimental group
Description:
Mindfulness training plus self-monitoring with access to data from wearable biosensor
Treatment:
Behavioral: Mindfulness training
Behavioral: Garmin Vivoactive 4 watch
MT
Experimental group
Description:
Mindfulness training (no access to wearable biosensor data)
Treatment:
Behavioral: Mindfulness training
Control
No Intervention group
Description:
Routine prenatal care alone

Trial contacts and locations

2

Loading...

Central trial contact

Alyssa Hernandez, DO; Anna Palatnik, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems